drugset / Trial / NCT00646776
Drug Interaction Study
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the exposure of rifabutin (RIB) when administered with atazanavir and ritonavir (ATV/RTV)
Timeline
- Start
- 2008-04
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atazanavir | Other / unclassified | 300 mg | Oral |
| Comparator | Rifabutin | Small molecule | 150 mg | Oral |
| Comparator | Ritonavir | Other / unclassified | 100 mg | Oral |
Indications
No indication recorded.